Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 11, Pages dju329-dju329
Publisher
Oxford University Press (OUP)
Online
2014-10-19
DOI
10.1093/jnci/dju329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model
- (2015) Libo Zhang et al. NEOPLASIA
- The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of ATM- and DNA-PKCs-Mediated DNA Damage Responses
- (2015) Bipasha Mukherjee et al. NEOPLASIA
- Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity
- (2014) Robert J. Canter et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies
- (2014) Mark Linch et al. Nature Reviews Clinical Oncology
- Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: Long-term results of a prospective trial
- (2014) Myles J.F. Smith et al. RADIOTHERAPY AND ONCOLOGY
- Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
- (2014) C. M. Lovly et al. Cancer Discovery
- Sarcoma Diagnosis in the Age of Molecular Pathology
- (2013) Elizabeth G. Demicco ADVANCES IN ANATOMIC PATHOLOGY
- Early onset recall pneumonitis during targeted therapy with sunitinib
- (2013) Takeshi Yuasa et al. BMC CANCER
- Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma
- (2013) Brian O'Sullivan et al. CANCER
- Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature
- (2013) A. Sharma et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates
- (2013) J. M. Meyer et al. CLINICAL CANCER RESEARCH
- Pazopanib, a new therapy for metastatic soft tissue sarcoma
- (2013) Jaap Verweij et al. EXPERT OPINION ON PHARMACOTHERAPY
- Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study
- (2013) Paul G. Corn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
- (2013) Alfredo Carrato et al. JOURNAL OF CLINICAL ONCOLOGY
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
- (2013) Mark A. Dickson et al. JOURNAL OF CLINICAL ONCOLOGY
- Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy
- (2013) Steven H. Lin et al. JNCI-Journal of the National Cancer Institute
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non-Small Cell Lung Cancer Expressing EML4-ALK
- (2013) Y. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
- (2013) Hae-June Lee et al. MOLECULAR CANCER THERAPEUTICS
- Strategies for optimizing the response of cancer and normal tissues to radiation
- (2013) Everett J. Moding et al. NATURE REVIEWS DRUG DISCOVERY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells
- (2013) Diana Marklein et al. PLoS One
- Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
- (2013) Jung Ryul Kim et al. PLoS One
- Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer
- (2013) Yuichiro Yoshioka et al. SURGERY TODAY
- Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis
- (2013) Katie R Hagen et al. Cell Division
- New Therapeutic Targets in Soft Tissue Sarcoma
- (2012) Elizabeth G. Demicco et al. ADVANCES IN ANATOMIC PATHOLOGY
- Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy
- (2012) A. Santoro et al. ANNALS OF ONCOLOGY
- An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
- (2012) M. Agulnik et al. ANNALS OF ONCOLOGY
- Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
- (2012) Le Su et al. CANCER CELL
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
- (2012) Giorgio V. Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway
- (2012) Seiichi Hosaka et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers
- (2012) Yaacov Richard Lawrence et al. JNCI-Journal of the National Cancer Institute
- Pazopanib and the treatment palette for soft-tissue sarcoma
- (2012) Vivien HC Bramwell LANCET
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer
- (2012) Ji-Youn Han et al. LUNG CANCER
- A retrospective study of SBRT of metastases in patients with primary sarcoma
- (2012) Christina Linder Stragliotto et al. MEDICAL ONCOLOGY
- Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs-Dependent DNA Double-Strand Break Repair
- (2012) M. Toulany et al. MOLECULAR CANCER RESEARCH
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Concise Drug Review: Pazopanib and Axitinib
- (2012) R. M. J. M. van Geel et al. ONCOLOGIST
- Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program
- (2012) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Improving Outcomes for Retroperitoneal Sarcomas: A Work in Progress
- (2012) Carol J. Swallow et al. Surgical Oncology Clinics of North America
- Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
- (2012) T Shimura et al. Oncogenesis
- Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
- (2011) E. P. Hui et al. ANNALS OF ONCOLOGY
- The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
- (2011) T. Powles et al. ANNALS OF ONCOLOGY
- A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
- (2011) Evan J. Wuthrick et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
- (2011) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
- (2011) Aimee M Crago et al. CURRENT OPINION IN ONCOLOGY
- Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
- (2011) Hong Shen et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting the AKT/GSK3β/Cyclin D1/Cdk4 Survival Signaling Pathway for Eradication of Tumor Radioresistance Acquired by Fractionated Radiotherapy
- (2011) Tsutomu Shimura et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients
- (2011) Steven E. Finkelstein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiotherapy for Pulmonary Metastases From Soft-Tissue Sarcomas: Excellent Local Lesion Control and Improved Patient Survival
- (2011) Sughosh Dhakal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Aberrant AKT activation drives well-differentiated liposarcoma
- (2011) A. Gutierrez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
- (2011) Carlos A Fedrigo et al. Radiation Oncology
- Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
- (2010) A. Italiano et al. ANNALS OF ONCOLOGY
- Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?
- (2010) M. Golshan et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
- (2010) Carlos H. Barrios et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
- (2010) S. Tariq Mahmood et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphoinositide-3-Kinase Inhibition Enhances Radiosensitization of Cervical Cancer In Vivo
- (2010) Yi Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status
- (2010) Nagata INTERNATIONAL JOURNAL OF ONCOLOGY
- Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition
- (2010) Claudia Blattmann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Angiogenic Blockade and Radiotherapy in Hepatocellular Carcinoma
- (2010) Kwan-Hwa Chi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas
- (2010) Sam S. Yoon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal Cancer
- (2010) Tom Dipetrillo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sunitinib-Induced Pseudoprogression After Whole-Brain Radiotherapy for Metastatic Renal Cell Carcinoma
- (2010) Paul J. Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
- (2010) C. Lance Cowey et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation
- (2010) Adrianne L. Myers et al. JOURNAL OF PEDIATRIC SURGERY
- Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
- (2010) Nicholas J. Hellenthal et al. JOURNAL OF UROLOGY
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- (2010) Jordi Barretina et al. NATURE GENETICS
- Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
- (2010) Frédéric Chibon et al. NATURE MEDICINE
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer
- (2010) Michael Staehler et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma
- (2009) Peter W. M. Chung et al. CANCER
- Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
- (2009) Johnny Kao et al. CANCER
- A Three-Gene Signature for Outcome in Soft Tissue Sarcoma
- (2009) A.-C. Hoffmann et al. CLINICAL CANCER RESEARCH
- Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma
- (2009) Sam S. Yoon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
- (2009) Achilles J. Fakiris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-Modulated Radiotherapy–Based Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Lung Cancer: Excellent Local Control
- (2009) Gregory M.M. Videtic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- (2009) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours
- (2009) P B Aleixo et al. JOURNAL OF CLINICAL PATHOLOGY
- Potent and Orally Active Small-Molecule Inhibitors of the MDM2−p53 Interaction
- (2009) Shanghai Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- Why Do Patients with Low-Grade Soft Tissue Sarcoma Die?
- (2008) Robert J. Canter et al. ANNALS OF SURGICAL ONCOLOGY
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
- (2008) Nabeel Pervaiz et al. CANCER
- Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma
- (2008) Shailendra Verma et al. CANCER TREATMENT REVIEWS
- Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases
- (2008) Susan B. Kesmodel et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program
- (2008) John M. Maris et al. PEDIATRIC BLOOD & CANCER
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
- (2008) Maura O'Leary et al. SEMINARS IN ONCOLOGY
- Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies
- (2007) Bridget F. Koontz et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started